Issels Integrative Immuno-Oncology March 29, 2018  

Two New Gene Therapies for Blood Cancers

Dear Friend,

2017 was a breakthrough year for cancer treatment. For the first time ever, the U.S. Food and Drug Administration (FDA) approved two gene therapies for blood cancers that have failed to respond to traditional forms of treatment.

Helping a Patient's Own Body Fight Cancer

The new treatments are known as CAR-T cell immunotherapy. What's exciting about these therapies is that they enhance the power of a patient's own immune system to seek out and kill cancer cells.

T cells are immune system cells responsible for attacking foreign substances in the body. First, a doctor extracts T cells from a patient's blood sample. The cells are then genetically modified to produce artificial proteins.

These proteins are called chimeric antigen receptors, or CAR, and they have the ability to recognize cancer cells in a patient. Once the modified T cells have been replicated, they're reintroduced to the patient's system to find and destroy cancer cells.

An "Explosion of Interest"

Kymriah, manufactured by Novartis, was approved for use with ALL, a form of leukemia that affects children and young adults. Gilead Sciences produces the other gene therapy, called Yescarta, which is used with non-Hodgkin lymphoma.

According to Dario Campano, an immunologist involved in the development of Kymriah, the approval of these therapies triggered an "explosion of interest." Campano expects continued research to lead to greater advancements in the technology.

Immunotherapy Cancer Treatment at Issels®

Issels® has long been a leader in the use of non-toxic, personally tailored cancer treatment programs that harness the power of a patient's immune system. Contact us to learn more about cancer vaccines and other treatments available at Issels®.

Two New Gene Therapies for Blood Cancers

Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »

Blood Cancer May Be Caused By Malaria Carrying Parasites

In the study, a group of scientists used mice to demonstrate how malaria-carrying parasites, such as mosquitoes, may lead to blood cancer. Although at present there is nothing to show that the same response may occur in humans, the results are promising as far as determining a surprising cause and effect between seemingly unrelated events that have confounded doctors for more than 50 years. Ultimately, a certain blood cancer called Burkitt's lymphoma presents.

Get the Full Story!

Off-Label Arthritis Drug Shows Promise in Blood Cancer Treatment

A common drug used in the treatment of arthritis may offer a new hope for cancer patients. At one thousandth of the cost of today's latest blood cancer treatment, Issels® wanted to let you know about this important discovery.

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:

Google +

Contact Info:

Phone: 888-447-7357


Treatments | Testimonials | Contact Us